# CardiaLen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardialen

- Industry: Medical Devices & Equipment
- Headquarters: Minneapolis, US
- Website: www.cardialen.com
- Total disclosed funding: $20M
- Latest round: Series B (Oct 10, 2018)
- Investors on record: 6

## About

Established in 2008 and based in Minnesota, US, CardiaLen, Inc. is a medical device company that provides pain-free internal cardioversion therapy for the treatment of atrial fibrillation (AF).

## Funding rounds

- Series B, Oct 10, 2018, $17M — HBM Partners, RiverVest Ventures Partners, Qiming Venture Partners, Cultivation Capital
- Series A, Jan 13, 2014, $2.5M — Cultivation Capital
- Series B, Sep 3, 2010, $0.3M — BioGenerator, St. Louis Arch Angels
- Series A, Jul 1, 2009 — BioGenerator, St. Louis Arch Angels

## Investors

- BioGenerator (https://capitalatlas.ai/funds/biogenerator) — Series A, Series B
- St. Louis Arch Angels — Series A, Series B
- Cultivation Capital (https://capitalatlas.ai/funds/cultivation-capital) — Series A, Series B
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B